InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Waltermire Robert E.. Director active across 1 company, notably Madrigal Pharmaceuticals, INC.. In total, 13 reports have been logged. Split: 0 buy · 4 sells. Total volume traded: €716k. Activity tracked since 16 January 2023. The latest transaction was disclosed on 5 March 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 条申报中的 13 条
Waltermire Robert E. is Senior VP, Chief Pharma Dev. at Madrigal Pharmaceuticals, INC. He has 13 filings in total. Across the 13 sampled recent filings, the sell amount is EUR 716325, the date range runs from 2023-01-18 to 2025-03-07, and the most frequent transaction nature is Levée d'options.